Jamjoom Pharma board proposes 15% dividend for H2 2023

04/04/2024 Argaam Exclusive

The board of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) recommended, on April 3, a 15% cash dividend, or SAR 1.5 per share, for the second half of 2023, the company said in a statement to Tadawul.

 

Dividend Details (H2 2023)

Current capital

SAR 700 mln

Number of shares

70 mln

Dividend

SAR 105 mln

Percentage of capital

15% (SAR 1.5 per share)

Record date

Shareholders of record and those registered with Edaa by the close of the second trading day following the record date

Payment date

To be set later

 

2023 Dividends

Total dividend

SAR 175 mln

Percentage of capital

25% (SAR 2.5 per share)
 

Dividend History (SAR/share) Corporate Actions

Announcement Ex-Dividend Payment Dividends
(M Riyal)		 Dividends * Notes
04/04/2024 04/06/2024 - 105.00 1.50
10/08/2023 20/08/2023 03/09/2023 70.00 1.00
Historical dividend per share adjusted for the effect of capital changes and bonus shares, if any

Dividend History

Consolidated cash dividend Cash dividend per share (SAR) * The stock price at the beginning of the period (SAR) Return on the base price
Last 3 Financial years N/A N/A N/A
Last 5 Financial years N/A N/A N/A
Last 10 Financial years N/A N/A N/A
Based on the beginning of the period (January 1 of the base year)

Historical Dividends

Jamjoom Pharmaceuticals Factory Co.
136.80
0.60 0.44 %

Most Read

ajax loading

Valuation Data (Latest Share Price)

P/E (TTM) 30.79
P/E Before Unusual Items (TTM) 30.79
P/BV 6.55
Dividend Yield 2.17 %
Market Cap. (M) 9,576.00
Return on Average Assets 19.12 %
Return on Average Equity 22.77 %

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.